Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
citizen petition
Pharma
Novo asks FDA to restrict compounding of legacy GLP-1 Victoza
Amid a broader campaign to snuff out compounded semaglutide, Novo Nordisk is shifting its outsourcing concerns to its legacy GLP-1 Victoza.
Fraiser Kansteiner
Jan 3, 2025 3:25pm
Jazz's lung cancer drug keeps approval despite failed trial
Oct 26, 2022 2:54pm
Pharmacy takes FDA to task in petition over tainted valsartan
Jun 20, 2019 10:16am
Watchdog sues FDA for stalling on Parkinson's drug warnings
Apr 30, 2019 11:02am
Pfizer blasts 'misleading' biosim messaging by peers
Aug 29, 2018 11:10am
Novo petitions FDA to require Victoza copies to go through clinical trials
Oct 9, 2017 2:55pm
